Seoulin Bioscience Co.Ltd Strategic Asset Allocation Index
Seoulin Bioscience Co.Ltd strategic asset allocation index. Seoulin Bioscience Co.Ltd (038070) has a Strategic Asset Allocation Index of 19.6% as of March 2025. Strategic assets (PP&E of ₩16.34 Billion plus long-term investments of ₩-) total ₩16.34 Billion, measured against net assets of ₩83.43 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Seoulin Bioscience Co.Ltd's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Seoulin Bioscience Co.Ltd (2013–2024)
Strategic asset allocation index of Seoulin Bioscience Co.Ltd from 2013 to 2024. This chart shows how Seoulin Bioscience Co.Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2013 to 2024. As of March 2025, the index stands at 19.6%, representing strategic assets of ₩16.34 Billion against net assets of ₩83.43 Billion KRW. Check tangible net worth ratio of Seoulin Bioscience Co.Ltd to evaluate the tangible quality of the company's equity base.
Seoulin Bioscience Co.Ltd Strategic Asset Allocation Index by Year (2013–2024)
Seoulin Bioscience Co.Ltd strategic asset allocation index by year from 2013 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Seoulin Bioscience Co.Ltd from 2013 to 2024, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Seoulin Bioscience Co.Ltd.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 19.8% | ₩16.63 Billion | ₩16.63 Billion | ₩- | ₩83.89 Billion | ▼ -2.9 pp |
| 2023 | 22.8% | ₩18.91 Billion | ₩18.91 Billion | ₩- | ₩83.06 Billion | ▲ +3.1 pp |
| 2022 | 19.7% | ₩16.49 Billion | ₩16.49 Billion | ₩- | ₩83.79 Billion | ▼ -0.3 pp |
| 2021 | 20.0% | ₩14.94 Billion | ₩14.94 Billion | ₩- | ₩74.86 Billion | ▼ -4.3 pp |
| 2020 | 24.3% | ₩14.54 Billion | ₩14.54 Billion | ₩- | ₩59.92 Billion | ▼ -29.3 pp |
| 2019 | 53.6% | ₩32.00 Billion | ₩25.92 Billion | ₩6.08 Billion | ₩59.71 Billion | ▼ -8.3 pp |
| 2018 | 61.9% | ₩33.23 Billion | ₩26.62 Billion | ₩6.62 Billion | ₩53.72 Billion | ▼ -3.0 pp |
| 2017 | 64.8% | ₩33.39 Billion | ₩27.24 Billion | ₩6.15 Billion | ₩51.49 Billion | ▲ +12.3 pp |
| 2016 | 52.5% | ₩25.53 Billion | ₩20.02 Billion | ₩5.51 Billion | ₩48.60 Billion | ▲ +5.0 pp |
| 2015 | 47.5% | ₩21.52 Billion | ₩15.98 Billion | ₩5.54 Billion | ₩45.30 Billion | ▲ +5.3 pp |
| 2014 | 42.2% | ₩18.22 Billion | ₩13.23 Billion | ₩4.99 Billion | ₩43.14 Billion | ▲ +10.1 pp |
| 2013 | 32.1% | ₩13.34 Billion | ₩13.34 Billion | ₩- | ₩41.57 Billion | — |